Webinar on CMS and Affordable Care Act:First of a series of AMCP Member Regulatory Briefings providing an overview of newly proposed regulations and agency guidance relevant to managed care pharmacy Watch RecordingClose
Value-Based Care
Discover key insights on value-based care to improve outcomes and cost-efficiency in managed care pharmacy. Access resources on innovative models, best practices, and strategies for delivering high-quality, patient-centered care.
In this guest blog post, Jennifer Graff, PharmD , discusses incorporating value in coverage decisions and how this applies to AMCP's efforts in addressing value and access.
In this guest blog post, Jennifer Graff, PharmD , discusses incorporating value in coverage decisions and how this applies to AMCP's efforts in addressing value and access.
Health care services provided by pharmacists are a vital part of comprehensive patient care. AMCP supports the use of payment arrangements for pharmacists that include performance-based metrics related to these health care services, on which some of the pharmacist’s reimbursement is based.
AMCP responded in a letter to the editor of Health Affairs stressing that managed care tools work to address the misalignment between drug prices and clinical value. In her latest blog post, AMCP CEO Susan Cantrell dives deeper into the reason behind the response and how it supported the need for value-based pricing.
From the PopHealth Week Archives: In this episode from April 14, 2020, PopHealth Week sits down with Stephen J. Spann, MD, MBA, and Tray Cockerell to discuss the launch of the nation's newest medical school and its important collaboration with one of the nation's most successful health plans serving both the Medicare and commercial populations via a variety of value-based health benefit plan arrangements.
From the PopHealth Week Archives: In this episode from September 19, 2019, PopHealth Week engages with visionary Clay Johnston, MD, PhD, inaugural dean of the Dell Medical School and vice president for medical affairs at the University of Texas at Austin on his plans for academic medicine and its evolving role in the volume to value transformation.
CMS outlining proposed changes to the calculation of best price under the Medicaid Drug Rebate Program (MDRP), particularly how manufacturers should account for value-based purchasing programs.
AMCP supports the use of value frameworks as a resource for determining the value of pharmaceuticals and other health technologies when the Frameworks are based on sound methods using good scientific evidence and economic models.